Poppe Kris, Glinoer Daniel
Academisch Ziekenhuis, Department of Endocrinology, Laarbeeklaan, Brussels.
Hum Reprod Update. 2003 Mar-Apr;9(2):149-61. doi: 10.1093/humupd/dmg012.
In the present review, an attempt was made to describe current knowledge and concepts concerning the complex relationships that link thyroid autoimmunity (TAI) and hypothyroidism with female and male infertility, as well as abnormalities occurring during pregnancy, such as pregnancy loss and maternal and fetal repercussions associated with hypothyroidism. In the case of infertility, although the clinical relevance of TAI is somewhat controversial, when all available information is considered the results strongly suggest that when infertility is due to well-defined female causes, autoimmunity is involved and TAI constitutes a useful marker of the underlying immune abnormality, independently of thyroid function disorders. In the case of pregnancy loss, the vast majority of available studies clearly establish that TAI (even with no overt thyroid dysfunction) is associated with a significant increase in miscarriage risk. To find an association, however, does not imply a causal relationship, and the aetiology of increased pregnancy loss associated with TAI remains presently not completely understood. With regard to maternal repercussions during gestation, the main risk associated with TAI is the occurrence of hypothyroidism and obstetric complications (premature birth, pre-eclampsia, etc.). Thus, systematic screening of TAI and hypothyroidism during early pregnancy, monitoring of thyroid function with/without L-thyroxine treatment and follow-up during post-partum have proved helpful and important in order to manage these patients adequately. Finally, with regard to potential repercussions affecting the offspring, recent evidence suggests that thyroid maternal underfunction, even when considered mild (or subclinical), may be associated with an impairment of fetal brain development. When present only during the first half of gestation, maternal hypothyroxinaemia is a risk factor for impaired fetal brain development, due to insufficient transfer of maternal thyroid hormones to the feto-placental unit. When hypothyroidism is not restricted to the first trimester and worsens as gestation progresses (as in untreated hypothyroidism), the fetus may also be deprived of adequate amounts of thyroid hormones during later neurological maturation and development, leading to poorer school performance and lower IQ.
在本综述中,我们试图描述有关甲状腺自身免疫(TAI)和甲状腺功能减退与女性和男性不育症之间复杂关系的现有知识和概念,以及孕期出现的异常情况,如流产以及与甲状腺功能减退相关的母婴影响。在不育症方面,尽管TAI的临床相关性存在一定争议,但综合所有可用信息,结果强烈表明,当不育症是由明确的女性原因引起时,自身免疫参与其中,TAI构成潜在免疫异常的有用标志物,与甲状腺功能障碍无关。在流产方面,绝大多数现有研究明确表明,TAI(即使没有明显的甲状腺功能障碍)与流产风险的显著增加有关。然而,发现一种关联并不意味着存在因果关系,目前与TAI相关的流产增加的病因仍未完全明确。关于孕期的母体影响,与TAI相关的主要风险是甲状腺功能减退和产科并发症(早产、先兆子痫等)的发生。因此,在孕早期对TAI和甲状腺功能减退进行系统筛查,在使用/不使用左甲状腺素治疗的情况下监测甲状腺功能,并在产后进行随访,已证明有助于并重要的是为了充分管理这些患者。最后,关于对后代的潜在影响,最近的证据表明,即使被认为是轻度(或亚临床)的母体甲状腺功能低下,也可能与胎儿脑发育受损有关。当仅在妊娠前半期出现时,母体甲状腺素血症是胎儿脑发育受损的危险因素,因为母体甲状腺激素向胎儿 - 胎盘单位的转移不足。当甲状腺功能减退不限于孕早期且随着妊娠进展而恶化(如未经治疗的甲状腺功能减退)时,胎儿在后期神经成熟和发育过程中也可能缺乏足够的甲状腺激素,导致学业成绩较差和智商较低。